Infection of the colon with the Gram-positive bacterium Clostridium difficile is potentially life
threatening, especially in elderly people and in patients who have dysbiosis of the gut …

Clostridium difficile is the main causative agent of antibiotic-associated and health care-
associated infective diarrhea. Recently, there has been growing interest in alternative …

Background Current therapies for recurrent Clostridioides difficile infection do not address
the disrupted microbiome, which supports C. difficile spore germination into toxin-producing …

Background A point-prevalence survey that was conducted in the United States in 2011
showed that 4% of hospitalized patients had a health care–associated infection. We …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Background Diarrhoea is the second leading cause of mortality in children worldwide, but
establishing the cause can be complicated by diverse diagnostic approaches and varying …

Objectives: Identify the etiology of nosocomial infections. Describe the appropriate
evaluation of nosocomial infections. Explain the treatment options available for nosocomial …

Background: To date, evidence for the efficacy of fecal microbiota transplantation (FMT) in
recurrent Clostridium difficile infection (CDI) has been limited to case series and open-label …

Clostridioides difficile infection occurs when the bacterium produces toxin that causes
diarrhea and inflammation of the colon. These guidelines indicate the preferred approach to …

Clostridium difficile infection (CDI) continues to affect patients in hospitals and communities
worldwide. The spectrum of clinical disease ranges from mild diarrhoea to toxic megacolon …